Today: 29 April 2026
Browse Category

NSE:INFOSYS 4 December 2025 - 9 April 2026

Sensex Falls 931 Points, Nifty Slides as Oil Prices Jump and Iran-U.S. Ceasefire Doubts Hit Indian Stocks

Sensex Falls 931 Points, Nifty Slides as Oil Prices Jump and Iran-U.S. Ceasefire Doubts Hit Indian Stocks

The Sensex dropped 931.25 points, or 1.20%, to 76,631.65 on Thursday as oil prices rebounded and doubts over an Iran-U.S. ceasefire rattled investors. Banks led the decline, while mid-caps, small-caps, and metals outperformed. Foreign investors extended their selling streak, and the rupee slipped to 92.6575 per dollar. Strait of Hormuz traffic remained near a standstill.
Sensex Today: Nifty Tops 23,100 as IT Stocks Lift India Shares Ahead of RBI Decision

Sensex Today: Nifty Tops 23,100 as IT Stocks Lift India Shares Ahead of RBI Decision

The Nifty 50 closed up 0.68% at 23,123.65 and the Sensex gained 510 points as IT stocks rallied ahead of earnings. Fourteen of 16 sectors advanced, led by Wipro, TCS, HCLTech, and Infosys. Hindalco and Vedanta rose after JPMorgan upgrades. The rupee strengthened to 93.0075 per dollar, but foreign investors pulled nearly $16 billion from Indian equities in March and April.
Why Sensex is falling today: Fed pause, rupee record low and Budget nerves hit Nifty

Why Sensex is falling today: Fed pause, rupee record low and Budget nerves hit Nifty

Indian shares fell Thursday, ending a two-day rally, as IT and auto stocks weighed on benchmarks ahead of Sunday’s federal budget. The Nifty 50 dropped 0.61% and the Sensex lost 0.71%. The rupee hit a record low near 92 per dollar amid continued foreign investor outflows. Market volatility rose, with India VIX up nearly 4%.
Stocks to Buy Today, 4 December 2025: Wipro, JK Tyre, Asian Paints, Indus Towers, Infosys, Hindustan Copper and More

Stocks to Buy Today, 4 December 2025: Wipro, JK Tyre, Asian Paints, Indus Towers, Infosys, Hindustan Copper and More

The Sensex fell 0.2% to 85,265 and the Nifty 50 dropped 47 points to 26,033 on Thursday, as profit-taking and a record-low rupee weighed on sentiment. Nifty IT outperformed, climbing 1.5% for a second session, with all constituents in the green. Foreign investors continued to sell for a fifth straight day. Wipro broke out above key technical levels, drawing fresh buy calls from analysts.

Stock Market Today

  • Nasdaq Futures Rise Ahead of Fed Decision and Major Tech Earnings
    April 29, 2026, 9:10 AM EDT. Nasdaq futures gained 0.4% ahead of the Federal Reserve's policy decision and earnings reports from tech giants Alphabet, Microsoft, Amazon, and Meta. Markets are cautious following a broad sell-off in major indices driven by chip stock weakness linked to slowing growth at AI firm OpenAI. Investors await the Fed's stance on inflation and interest rates, with crude oil prices rising amid unresolved US-Iran tensions. The Fed is expected to hold rates steady in Jerome Powell's final meeting before his replacement, Kevin Warsh, awaits Senate approval. Key focus remains on AI capital expenditure and the potential for further rate hikes in 2024. Earnings from AbbVie, AstraZeneca, Total Energies, UBS, and GSK are also in focus.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
NEW YORK, April 29, 2026, 09:03 EDT Visa Inc. shares climbed about 5% in premarket trading on Wednesday after the world’s largest payments network beat Wall Street profit estimates, lifted its full-year earnings outlook and announced a new $20 billion share repurchase program. (Reuters) The report landed as investors were looking for signs that higher fuel costs, inflation and the Middle East conflict were starting to hit card spending or cross-border travel. Visa’s numbers matter beyond its own stock because the company earns from transaction flows across its network, rather than taking credit risk on card loans. (Reuters) Visa said
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop